Introduce Ultragenyx’s leadership to government, discuss policies related to rare disease therapies including B.C.'s life sciences strategy, and where opportunities may align for the government and Ultragenyx to support rare-disease patients.
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|